Clinical Laserthermia Systems AB (publ) - Asset Resilience Ratio

Latest as of June 2023: 0.31%

Clinical Laserthermia Systems AB (publ) (CLS-B) has an Asset Resilience Ratio of 0.31% as of June 2023. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read Clinical Laserthermia Systems AB (publ) debt and liabilities for a breakdown of total debt and financial obligations.

Liquid Assets

Skr139.00K

≈ $14.96K USD Cash + Short-term Investments

Total Assets

Skr44.47 Million

≈ $4.79 Million USD All company assets

Resilience Assessment

Low

Financial Resilience Level

Asset Resilience Ratio Trend (2017–2022)

This chart shows how Clinical Laserthermia Systems AB (publ)'s Asset Resilience Ratio has changed over time. See net assets of Clinical Laserthermia Systems AB (publ) for net asset value and shareholders' equity analysis.

Liquid Assets Composition Over Time

This chart breaks down Clinical Laserthermia Systems AB (publ)'s liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see Clinical Laserthermia Systems AB (publ) (CLS-B) total market value.

Current Liquid Assets Breakdown

Component	Amount	% of Total Assets
Cash & Equivalents	Skr0.00	0%
Short-term Investments	Skr139.00K	0.31%
Total Liquid Assets	Skr139.00K	0.31%

Asset Resilience Insights

Limited Liquidity: Clinical Laserthermia Systems AB (publ) maintains only 0.31% of assets in liquid form.
This low level may indicate efficient asset utilization but could pose risks during economic downturns.
The company has significant short-term investments, indicating active treasury management.

Clinical Laserthermia Systems AB (publ) Industry Peers by Asset Resilience Ratio

Compare Clinical Laserthermia Systems AB (publ)'s asset resilience ratio with other companies in the same industry.

Company	Industry	Asset Resilience Ratio
Demant A/S CO:DEMANT	Medical Devices	-2.59%
Double Medical Technology Inc SHE:002901	Medical Devices	7.79%
Beijing Wandong Medical Technology Co Ltd SHG:600055	Medical Devices	4.92%
Sinocare Inc SHE:300298	Medical Devices	3.53%
MODULIGHT OY EO 1 F:78W	Medical Devices	22.31%
Diagnostic Medical Systems SA PA:ALDMS	Medical Devices	1.39%
Theradiag SA PA:ALTHE	Medical Devices	15.59%
Nova EYE Medical Ltd AU:EYE	Medical Devices	11.08%

Annual Asset Resilience Ratio for Clinical Laserthermia Systems AB (publ) (2017–2022)

The table below shows the annual Asset Resilience Ratio data for Clinical Laserthermia Systems AB (publ).

Year	Asset Resilience Ratio (%)	Liquid Assets	Total Assets	Change
2022-12-31	0.28%	Skr139.49K ≈ $15.01K	Skr49.51 Million ≈ $5.33 Million	-43.86pp
2021-12-31	44.14%	Skr29.46 Million ≈ $3.17 Million	Skr66.74 Million ≈ $7.18 Million	+18.74pp
2020-12-31	25.40%	Skr11.28 Million ≈ $1.21 Million	Skr44.40 Million ≈ $4.78 Million	+16.07pp
2019-12-31	9.32%	Skr3.60 Million ≈ $387.93K	Skr38.67 Million ≈ $4.16 Million	-31.96pp
2018-12-31	41.28%	Skr23.95 Million ≈ $2.58 Million	Skr58.02 Million ≈ $6.24 Million	+10.97pp
2017-12-31	30.31%	Skr13.62 Million ≈ $1.47 Million	Skr44.94 Million ≈ $4.84 Million	--

pp = percentage points

About Clinical Laserthermia Systems AB (publ)

ST:CLS-B Sweden Medical Devices

Market Cap

$11.57 Million

Skr107.52 Million SEK

Market Cap Rank

#26505 Global

#570 in Sweden

Share Price

Skr3.45

Change (1 day)

-4.83%

52-Week Range

Skr2.62 - Skr11.82

All Time High

Skr1089.26